We are live on
!
Find out more
IA
Investor AB Portfolio holdings
AUM
$15.1B
1-Year Est. Return
29.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.87%
1 Year Est. Return
+29.02%
3 Year Est. Return
+79.02%
5 Year Est. Return
+98.76%
10 Year Est. Return
+341.52%
AUM
$4.52B
AUM Growth
+$251M
(+5.9%)
Cap. Flow
+$1.1M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
2
Reduced
–
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cellebrite
CLBT
|
+$770K |
| 2 |
Microchip Technology
MCHP
|
+$550K |
| 3 |
Blackrock
BLK
|
+$487K |
| 4 |
Check Point Software Technologies
CHKP
|
+$188K |
| 5 |
Coherent
COHR
|
+$50K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Onto Innovation
ONTO
|
+$748K |
| 2 |
Cognex
CGNX
|
+$203K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 99.57% |
| 2 | Healthcare | 0.34% |
| 3 | Technology | 0.07% |
| 4 | Consumer Discretionary | 0.02% |
Similar funds
MSV
AT
UM
RFC
FCAS
GF
Investor AB's Q4 2024 Portfolio in Review
As of Q4 2024, Investor AB held 10 positions worth $4.52B, up 5.9% from $4.27B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Investor AB's Q4 2024 filing shows 3 new, 2 increased and 2 closed positions. Its largest new stake was Cellebrite: 40,000 shares worth $881K. The largest sale was Onto Innovation, an estimated $748K.
By sector, the portfolio is most concentrated in Financials at 100% of assets, up from 100% a quarter earlier, followed by Healthcare and Technology.
- Investor AB's largest Q4 2024 buy was Cellebrite: 40,000 shares worth $881K.
- Investor AB added most to Check Point Software Technologies in Q4 2024, an estimated $188K increase.
- Investor AB fully exited Onto Innovation in Q4 2024, selling an estimated $748K.
- Investor AB's ten largest holdings make up 100% of its $4.52B portfolio in Q4 2024.
- Investor AB opened 3 new positions and closed 2 in Q4 2024.
- Investor AB's portfolio value rose 5.9% quarter-over-quarter to $4.52B.
Based on Investor AB's 13F filing for Q4 2024, filed 14 Feb 2025.